Neumora Therapeutics (NMRA) Non-Current Assets (2022 - 2026)
Neumora Therapeutics (NMRA) reported Non-Current Assets of $375,000 for Q2 2026, down 59.1% from $916,000 a year earlier and down 15.3% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Neumora Therapeutics posted Non-Current Assets of $510,000, down 82.5% from FY2024.
- Non-Current Assets has declined for three consecutive years, with a three-year compound annual growth rate of -76.3% (FY2022 to FY2025).
- By year, Non-Current Assets came in at $2.92 million in FY2024 (-83.7%), $17.92 million in FY2023 (-53.2%) and $38.28 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets in data going back to Q4 2022.
- Year over year, Non-Current Assets has now declined in each of the last eight quarters, with an average decline of 77.7% over the last eight quarters.
- Over the past five years, the year-over-year decline in Non-Current Assets ranged from 53.2% (Q4 2023) to 85.1% (Q2 2025).
- Per Business Quant data, the three quarters before Q2 2026 came in at $443,000 (Q1 2026), $510,000 (Q4 2025) and $751,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.65 Bn | 1,100.24 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 615.89 Bn | 534.41 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 505.03 Bn | 478.14 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 368.78 Bn | 323.16 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.66 Bn | 262.65 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 262.09 Bn | 235.78 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.57 Bn | 191.97 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.05 Bn | 165.25 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.60 Bn | 117.25 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Neumora Therapeutics | 81.84 Mn | -536.12 Mn | - | 375,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 375,000.00 |
| Mar 31, 2026 | 443,000.00 |
| Dec 31, 2025 | 510,000.00 |
| Sep 30, 2025 | 751,000.00 |
| Jun 30, 2025 | 916,000.00 |
| Mar 31, 2025 | 1.88 Mn |
| Dec 31, 2024 | 2.92 Mn |
| Sep 30, 2024 | 3.93 Mn |
| Jun 30, 2024 | 6.15 Mn |
| Mar 31, 2024 | 7.43 Mn |
| Dec 31, 2023 | 17.92 Mn |
| Sep 30, 2023 | 19.01 Mn |
| Dec 31, 2022 | 38.28 Mn |
API Access
Neumora Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();